AMAG Pharmaceuticals to Present at the Needham Healthcare Conference
Needham Healthcare Conference 2013
LEXINGTON, Mass. -- April 26, 2013
AMAG Pharmaceuticals, Inc.(NASDAQ: AMAG) today announced thatWilliam Heiden,
AMAG’s chief executive officer, will present at the Needham Healthcare
ConferenceonWednesday, May 1, 2013at12:50 p.m. Eastern time. The
presentation will include a company overview and business update.
A live webcast of the presentation will be accessible through the Investors
section of the company’s website atwww.amagpharma.com. Following the
conference, the webcast will be archived on theAMAG Pharmaceuticals,
Inc.website untilJune 1, 2013.
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that
manufactures and markets Feraheme® (ferumoxytol) Injection for Intravenous
(IV) use in the United States. Along with driving organic growth of its lead
product, AMAG intends to expand its portfolio with additional commercial-stage
specialty pharmaceuticals. The company is seeking complementary products that
leverage the company’s commercial footprint and focus on hematology and
oncology centers and hospital infusion centers. For additional company
information, please visit www.amagpharma.com.
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303
Press spacebar to pause and continue. Press esc to stop.